Literature DB >> 9041353

A population-based seroepidemiologic study of human granulocytic ehrlichiosis and Lyme borreliosis on the west coast of Sweden.

J S Dumler1, L Dotevall, R Gustafson, M Granström.   

Abstract

Ehrlichioses are emerging infections in the United States. Human granulocytic ehrlichiosis (HGE) and Lyme borreliosis (LB) are acquired after Ixodes ricinus-complex tick bites. An ongoing seroepidemiologic study of the 185 of the 356 permanent residents of the Koster Islands in Sweden was expanded to include ehrlichioses. Ehrlichial antibodies were measured by IFA using Ehrlichia equi and Ehrlichia chaffeensis. Borrelia burgdorferi IgG ELISA-seropositive subjects were confirmed by Western blot. E. equi and E. chaffeensis antibodies (titer > or = 80) were found in 21 (11.4%) and 2 (1.1%) of 185 samples, respectively. Antibodies to B. burgdorferi were found in 25 (13.5%) of 185. Six persons were seropositive for both HGE and LB. Among data from questionnaires, clinical symptoms, antibiotic treatments, or tick bites were not more frequent in E. equi- or B. burgdorferi-seropositive than -seronegative persons. The seroprevalence of HGE was similar to that of Lyme borreliosis. Prospective studies of European HGE are needed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041353     DOI: 10.1093/infdis/175.3.720

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1.

Authors:  R E Barnewall; N Ohashi; Y Rikihisa
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Analysis of pathogen co-occurrence in host-seeking adult hard ticks from Serbia.

Authors:  Snežana Tomanović; Dimosthenis Chochlakis; Zeljko Radulović; Marija Milutinović; Sanja Cakić; Darko Mihaljica; Yannis Tselentis; Anna Psaroulaki
Journal:  Exp Appl Acarol       Date:  2012-07-07       Impact factor: 2.132

3.  Characterization of monoclonal antibodies to the 44-kilodalton major outer membrane protein of the human granulocytic ehrlichiosis agent.

Authors:  H Y Kim; Y Rikihisa
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

4.  Serological evidence of human granulocytic ehrlichiosis in Switzerland.

Authors:  N Pusterla; R Weber; C Wolfensberger; G Schär; R Zbinden; W Fierz; J E Madigan; J S Dumler; H Lutz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

Review 5.  Human granulocytic anaplasmosis.

Authors:  Johan S Bakken; J Stephen Dumler
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

6.  PCR detection and serological evidence of granulocytic ehrlichial infection in roe deer (Capreolus capreolus) and chamois (Rupicapra rupicapra).

Authors:  Jorge S Liz; John W Sumner; Kurt Pfister; Michel Brossard
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 7.  Coinfections acquired from ixodes ticks.

Authors:  Stephen J Swanson; David Neitzel; Kurt D Reed; Edward A Belongia
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

8.  Detection and identification of Ehrlichia, Borrelia burgdorferi sensu lato, and Bartonella species in Dutch Ixodes ricinus ticks.

Authors:  L M Schouls; I Van De Pol; S G Rijpkema; C S Schot
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

9.  Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates.

Authors:  M D Ravyn; J L Goodman; C B Kodner; D K Westad; L A Coleman; S M Engstrom; C M Nelson; R C Johnson
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Identification of Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato in patients with erythema migrans.

Authors:  D Hulínská; J Votýpka; D Vanousová; J Hercogová; V Hulínský; H Drevová; Z Kurzová; L Uherková
Journal:  Folia Microbiol (Praha)       Date:  2009-08-02       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.